About Matthew Gunnison
Matthew Gunnison is a director at Nirrin Technologies.
Matthew Gunnison first appears on SEC filings in 2024.
Experience
This experience comes from Matthew Gunnison's profile and from SEC filings. For roles taken from filings, the years are when the filings name Matthew Gunnison in the role, so the role may have started earlier or lasted longer.
BI
Biosynth Current
Chief Executive Officer
2024 – Present
Nirrin Technologies, Inc. Current
Director
2021 – Present · Billerica, MA
Nirrin sells measurement instruments and analytics to biopharmaceutical development and manufacturing teams.
GB
Gamma Biosciences
Chief Executive Officer
2019 – 2024
GH
GE Healthcare
Global Head, Corporate Development
2011 – 2019
SL
Sidley Austin LLP
Associate, Corporate (M&A)
2007 – 2011
Key Colleagues at Startups
The people Matthew Gunnison works with at each company, as listed on that company's latest Form D.
Nirrin Technologies, Inc. · Form D, Jun 15, 2026
